Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers corporate updates and financial results for the first quarter of 2019, announced on May 13, 2019. The Company is a foreign private issuer based in Israel.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the provided text.
Material Changes and Operational Updates
- Financial Results: The Company announced its Q1 2019 financial results, though specific metrics are not listed in this summary text.
- Clinical Trial Expansion: Mayo Clinic has been identified as the second trial site participating in the Company's ongoing pilot study of the C-Scan system in the United States.
Guidance, Outlook, and Risks
The filing incorporates "Forward Looking Statements" from the press release (Exhibit 99.2) by reference. The text does not explicitly detail specific guidance, risk factors, or contingencies beyond the general incorporation of these statements.
Investor Verification Checklist
- Review Exhibit 99.1 for specific Q1 2019 revenue, net loss, and cash position figures.
- Verify the scope and timeline of the C-Scan pilot study at Mayo Clinic as detailed in Exhibit 99.2.
- Examine the "Forward Looking Statements" section in the attached press releases for updated guidance and risk disclosures.
- Confirm the status of the Post-Effective Amendment No. 1 to Form S-8 and Form F-3 Registration Statements referenced in the filing.